Community Healthcare Analyst Ratings
Community Healthcare Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
02/16/2023 | 4.78% | Baird | $38 → $43 | Maintains | Outperform |
01/17/2023 | 16.96% | Truist Securities | $43 → $48 | Maintains | Buy |
01/17/2023 | 9.65% | Piper Sandler | $41 → $45 | Maintains | Overweight |
01/13/2023 | 7.21% | Janney Montgomery Scott | → $44 | Upgrades | Neutral → Buy |
10/07/2022 | -0.1% | Piper Sandler | $45 → $41 | Maintains | Overweight |
09/27/2022 | 4.78% | Evercore ISI Group | $45 → $43 | Maintains | Outperform |
07/11/2022 | 7.21% | Truist Securities | $49 → $44 | Maintains | Buy |
11/25/2020 | — | Evercore ISI Group | Upgrades | In-Line → Outperform | |
08/06/2020 | 34.02% | Piper Sandler | $38 → $55 | Maintains | Overweight |
06/08/2020 | 4.78% | Evercore ISI Group | → $43 | Downgrades | Outperform → In-Line |
05/14/2020 | -7.41% | Piper Sandler | $35 → $38 | Maintains | Overweight |
05/07/2020 | -2.53% | B. Riley Securities | → $40 | Downgrades | Buy → Neutral |
04/23/2020 | -4.97% | SunTrust Robinson Humphrey | $46 → $39 | Maintains | Buy |
03/20/2020 | -2.53% | B. Riley Securities | $47 → $40 | Upgrades | Neutral → Buy |
03/06/2020 | 14.52% | B. Riley Securities | $42 → $47 | Maintains | Neutral |
02/28/2020 | 26.71% | Baird | $48 → $52 | Maintains | Outperform |
11/18/2019 | — | Piper Sandler | Upgrades | Hold → Buy | |
11/07/2019 | 2.34% | B. Riley Securities | $38 → $42 | Maintains | Neutral |
07/10/2019 | — | Janney Montgomery Scott | Downgrades | Buy → Neutral | |
04/23/2019 | — | Berenberg | Initiates Coverage On | → Buy | |
04/10/2019 | -2.53% | Baird | → $40 | Initiates Coverage On | → Outperform |
03/28/2019 | -7.41% | DA Davidson | → $38 | Initiates Coverage On | → Neutral |
11/16/2018 | -95.13% | UBS | → $2 | Initiates Coverage On | → Sell |
11/12/2018 | -24.46% | B. Riley Securities | $32 → $31 | Maintains | Neutral |
08/13/2018 | -22.03% | B. Riley Securities | $28 → $32 | Maintains | Neutral |
05/11/2018 | -31.77% | B. Riley Securities | $27 → $28 | Maintains | Neutral |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
02/16/2023 | 4.78% | 貝爾德 | $38 → $43 | 維護 | 跑贏大盤 |
01/17/2023 | 16.96% | Truist證券 | $43 → $48 | 維護 | 買 |
01/17/2023 | 9.65% | 派珀·桑德勒 | $41 → $45 | 維護 | 超重 |
01/13/2023 | 7.21% | 詹尼·蒙哥馬利·斯科特 | → $44 | 升級 | 中性→購買 |
10/07/2022 | -0.1% | 派珀·桑德勒 | $45 → $41 | 維護 | 超重 |
09/27/2022 | 4.78% | Evercore ISI集團 | $45 → $43 | 維護 | 跑贏大盤 |
07/11/2022 | 7.21% | Truist證券 | $49 → $44 | 維護 | 買 |
11/25/2020 | — | Evercore ISI集團 | 升級 | 線內→表現優異 | |
08/06/2020 | 34.02% | 派珀·桑德勒 | $38 → $55 | 維護 | 超重 |
06/08/2020 | 4.78% | Evercore ISI集團 | → $43 | 評級下調 | 勝過→同線 |
05/14/2020 | -7.41% | 派珀·桑德勒 | $35 → $38 | 維護 | 超重 |
05/07/2020 | -2.53% | B.萊利證券 | → $40 | 評級下調 | 購買→中性 |
04/23/2020 | -4.97% | SunTrust Robinson Humphrey | $46 → $39 | 維護 | 買 |
03/20/2020 | -2.53% | B.萊利證券 | $47 → $40 | 升級 | 中性→購買 |
03/06/2020 | 14.52% | B.萊利證券 | $42 → $47 | 維護 | 中性 |
02/28/2020 | 26.71% | 貝爾德 | $48 → $52 | 維護 | 跑贏大盤 |
11/18/2019 | — | 派珀·桑德勒 | 升級 | 持有→購買 | |
11/07/2019 | 2.34% | B.萊利證券 | $38 → $42 | 維護 | 中性 |
07/10/2019 | — | 詹尼·蒙哥馬利·斯科特 | 評級下調 | 購買→中性 | |
04/23/2019 | — | 貝倫伯格 | 開始承保 | →購買 | |
04/10/2019 | -2.53% | 貝爾德 | → $40 | 開始承保 | →跑贏大盤 |
03/28/2019 | -7.41% | 達·戴維森 | → $38 | 開始承保 | →中性 |
11/16/2018 | -95.13% | 瑞銀集團 | → $2 | 開始承保 | →銷售 |
11/12/2018 | -24.46% | B.萊利證券 | $32 → $31 | 維護 | 中性 |
08/13/2018 | -22.03% | B.萊利證券 | $28 → $32 | 維護 | 中性 |
05/11/2018 | -31.77% | B.萊利證券 | $27 → $28 | 維護 | 中性 |
What is the target price for Community Healthcare (CHCT)?
社區醫療(CHCT)的目標價格是多少?
The latest price target for Community Healthcare (NYSE: CHCT) was reported by Baird on February 16, 2023. The analyst firm set a price target for $43.00 expecting CHCT to rise to within 12 months (a possible 4.78% upside). 7 analyst firms have reported ratings in the last year.
Baird於2023年2月16日報道了社區醫療保健(NYSE:CHCT)的最新目標價。這家分析公司將目標價定為43.00美元,預計CHCT將在12個月內升至(可能上漲4.78%)。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Community Healthcare (CHCT)?
社區醫療(CHCT)的最新分析師評級是多少?
The latest analyst rating for Community Healthcare (NYSE: CHCT) was provided by Baird, and Community Healthcare maintained their outperform rating.
Baird提供了對社區醫療保健(紐約證券交易所代碼:CHCT)的最新分析師評級,社區醫療保健保持了其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for Community Healthcare (CHCT)?
社區醫療(CHCT)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Community Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Community Healthcare was filed on February 16, 2023 so you should expect the next rating to be made available sometime around February 16, 2024.
分析師在進行了廣泛的研究後得出股票評級,其中包括查閲公共財務報表,與社區醫療保健的高管和客户交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。社區衞生保健的上一次評級是在2023年2月16日提交的,所以你應該預計下一次評級將在2024年2月16日左右的某個時候提供。
Is the Analyst Rating Community Healthcare (CHCT) correct?
分析師對社區醫療保健(CHCT)的評級正確嗎?
While ratings are subjective and will change, the latest Community Healthcare (CHCT) rating was a maintained with a price target of $38.00 to $43.00. The current price Community Healthcare (CHCT) is trading at is $41.04, which is within the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的社區醫療保健(CHCT)評級保持不變,目標價在38.00美元至43.00美元之間。目前Community Healthcare(CHCT)的交易價格為41.04美元,在分析師的預測範圍內。